$Intelligent Bio Solutions(INBS.US)$Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
Intelligent Bio Solutions Inc. (Nasdaq: INBS) has successfully completed biocompatibility testing for its Intelligent Fingerprinting Drug Screening System, a important step in the FDA 510(k) regulatory clearance process.
The study, conducted according to ISO 10993 standards, confirmed the safety of all system materials for medical device use. This milestone ...